Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Genetic and phenotypic variation in UGT2B17, a testosterone-metabolizing enzyme, is associated with BMI in males.

Zhu AZ, Cox LS, Ahluwalia JS, Renner CC, Hatsukami DK, Benowitz NL, Tyndale RF.

Pharmacogenet Genomics. 2015 May;25(5):263-9. doi: 10.1097/FPC.0000000000000135.

2.

Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake.

Zhu AZ, Zhou Q, Cox LS, Ahluwalia JS, Benowitz NL, Tyndale RF.

PLoS One. 2013 Aug 2;8(8):e70938. doi: 10.1371/journal.pone.0070938. Print 2013.

3.

Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption.

Moran VE.

Front Pharmacol. 2012 Oct 10;3:173. doi: 10.3389/fphar.2012.00173. eCollection 2012.

4.

Glucuronidation of trans-3'-hydroxycotinine by UGT2B17 and UGT2B10.

Chen G, Giambrone NE, Lazarus P.

Pharmacogenet Genomics. 2012 Mar;22(3):183-90. doi: 10.1097/FPC.0b013e32834ff3a5.

5.

Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms.

Chen G, Giambrone NE Jr, Dluzen DF, Muscat JE, Berg A, Gallagher CJ, Lazarus P.

Cancer Res. 2010 Oct 1;70(19):7543-52. doi: 10.1158/0008-5472.CAN-09-4582. Epub 2010 Sep 28.

6.

Meconium nicotine and metabolites by liquid chromatography-tandem mass spectrometry: differentiation of passive and nonexposure and correlation with neonatal outcome measures.

Gray TR, Magri R, Shakleya DM, Huestis MA.

Clin Chem. 2008 Dec;54(12):2018-27. doi: 10.1373/clinchem.2008.109173. Epub 2008 Oct 9.

Supplemental Content

Support Center